BTLA and neoplasm: All mice treated with paclitaxel and anti-BTLA Ab 20 μg/mouse and 40% of mice treated with paclitaxel and anti-BTLA Ab 10 μg/mouse were still alive even 100 days after the WF-3/Luc tumor challenge (p < 0.001, log-rank test, Fig. 1d).